ORIGINAL RESEARCH article

Front. Pharmacol., 25 March 2019

Sec. Renal Pharmacology

Volume 10 - 2019 | https://doi.org/10.3389/fphar.2019.00224

RETRACTED: CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway

  • MS

    Meng-Yao Sun 1,2

  • SW

    Su-Juan Wang 1,3

  • XL

    Xiao-Qin Li 1

  • YS

    Yu-Li Shen 1

  • JL

    Jian-Rao Lu 4

  • XT

    Xin-Hui Tian 1

  • KR

    Khalid Rahman 5

  • LZ

    Li-Jun Zhang 1*

  • HN

    Hua Nian 6*

  • HZ

    Hong Zhang 1*

  • 1. Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China

  • 2. Central Laboratory, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

  • 3. Department of Drug Preparation, Hospital of TCM and Hui Nationality Medicine, Ningxia Medical University, Wuzhong, China

  • 4. Department of Nephrology, Seventh People’s Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China

  • 5. School of Pharmacy and Biomolecular Sciences, Faculty of Science, Liverpool John Moores University, Liverpool, United Kingdom

  • 6. Department of Pharmacy, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Summary

Citation

Sun M-Y, Wang S-J, Li X-Q, Shen Y-L, Lu J-R, Tian X-H, Rahman K, Zhang L-J, Nian H and Zhang H (2019) RETRACTED: CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway. Front. Pharmacol. 10:224. doi: 10.3389/fphar.2019.00224

Received

25 September 2018

Accepted

22 February 2019

Published

25 March 2019

Volume

10 - 2019

Edited by

Matthew Griffin, National University of Ireland Galway, Ireland

Reviewed by

Peter Jon Nelson, Ludwig Maximilian University of Munich, Germany; Ana Belen Sanz, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Spain

Updates

These authors have contributed equally to this work

This article was submitted to Renal Pharmacology, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics